van der Nelson, Helen
O’Brien, Stephen http://orcid.org/0000-0003-3133-8920
Lenguerrand, Erik
Marques, Elsa
Alvarez, Mary
Mayer, Michelle
Burnard, Sara
Siassakos, Dimitrios
Draycott, Timothy
Funding for this research was provided by:
Ferring
Article History
Received: 11 July 2018
Accepted: 6 December 2018
First Online: 3 January 2019
Authors’ information
: Not applicable.
: The IMox study has been approved by the South Central – Oxford B Research Ethics Committee, UK on 28 October 2014, reference number 14/SC/1312, the Medicines and Healthcare products Regulatory Agency on 30 October 2014 and the Health Research Authority on 3 August 2016. Written consent has been gained antenatally from all trial participants. Consent may be withdrawn at any time without a reason being stated.
: Not applicable.
: TD has acted as a consultant for Ferring Pharmaceuticals Ltd. DS has received sponsorship to attend two conferences from Ferring Pharmaceuticals Ltd. and is a member of their GLOBE Personal Development Scheme. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.